imipramine has been researched along with Apraxia in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GAL, JC | 1 |
| SIGWALD, J | 1 |
2 other studies available for imipramine and Apraxia
| Article | Year |
|---|---|
[Study of the action of imipramine on parkinsonian akinesia].
Topics: Apraxias; Imipramine; Parkinson Disease; Psychopharmacology | 1960 |
[Treatment of parkinsonian akinesia].
Topics: Apraxias; Humans; Imipramine; Iproniazid; Monoamine Oxidase Inhibitors; Parkinson Disease | 1961 |